Nasdaq approves listing of Canary Capital's Injective (INJ) staking ETF
Original headline나스닥, 캐너리 캐피털 인젝티브(INJ) 스테이킹 ETF 상장 승인
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Nasdaq approved Canary Capital's staking ETF for Injective's INJ token, with the product set to trade under the ticker INJC following a Form 8-A filing with the SEC on November 3. The fund will hold INJ directly while pursuing both price exposure and staking rewards, giving investors a way to earn network validation yield without buying or staking the token themselves. The listing marks another step in the expansion of crypto ETFs beyond bitcoin and ether into altcoin and yield-bearing structures. What to watch next is the actual launch date and initial inflows for INJC, and whether the approval encourages further staking-based altcoin ETF filings.
Muhabbit's AI wrote this summary in its own words from TokenPost's report and translated it from Korean. It can get details wrong, so check the source.
Named in this story
Nasdaq, Canary Staked INJ ETF, Canary Capital, Injective (INJ), INJ (INJ), SEC
A linked name opens that asset's sentiment page.